Table 5 Characteristics of the performed tests.
From: Reference intervals for coagulation parameters in non-pregnant and pregnant women
Test (units) | MRI | Method | Reagent | Batch numbers | Stability (h) |
|---|---|---|---|---|---|
AT (%) | 83–128 | Chromogenic assay | HemosIL Liquid Antithrombin kit | Cat.No.0020300400 Cat.No.0020030100 | 48 |
PC (%) | 70–140 | Chromogenic assay | HemosIL Protein C kit | Cat.No.0020300500 | 120 |
fPS (%) | 63.5–149.0 | Clotting time method (by turbidimetry) | HemosIL Protein S kit | Cat.No.0020302000 | 8 |
LA normalized ratio | < 1.2 | Clotting time method (by turbidimetry) | HemosILdRVVT Screen and dRVVT Confirm kit | Cat.No.0020301500 Cat.No.0020301600 | 72 |
D-dimer (μg/ml) | < 0.24 | Latex enhanced immunoassay | HemosIL D-Dimer HS kit | Cat.No.0020007700 | 96 |
FDP (μg/ml) | < 2.01 | Latex enhanced immunoassay | HemosIL FDP kit | Cat.No.0020009900 | 72 |
FVII (%) | 50–129 | Clotting time method (by turbidimetry) | HemosIL Factor VII Deficient Plasma | Cat.No.0020011700 | 24 |
FVIII (%) | 50–150 | Clotting time method (by turbidimetry) | HemosIL Factor VIII Deficient Plasma | Cat.No.0020011800 | 4 |
